Estimates
Source: S&P Capital IQ consensus via Xpressfeed · Generated 2026-07-29.
FY2027 EPS estimates are down 3.1% over 180 days while revenue estimates rose 2.9%
FY2028 carries the same split over 90 days — revenue +2.1%, normalized EPS -2.9%. Neither line has moved at all in the last 30 days, so this is a one-to-six-month-old revision rather than a fresh one. The feed has no 180-day mark for FY2028.
Currency: IDR · Scale: money in millions, billions, absolute · Point-in-time consensus; Δ90d is Now versus 90d.
| Metric | FY | 180d | 90d | 30d | Now | Δ90d |
|---|---|---|---|---|---|---|
| EPS (normalized) | FY2027 | IDR 93.55 | IDR 91.24 | IDR 90.63 | IDR 90.63 | -0.7% |
| EPS (normalized) | FY2028 | — | IDR 107.0 | IDR 103.9 | IDR 103.9 | -2.9% |
| Revenue | FY2027 | IDR 83,927 | IDR 85,029 | IDR 86,373 | IDR 86,373 | +1.6% |
| Revenue | FY2028 | — | IDR 96,490 | IDR 98,540 | IDR 98,540 | +2.1% |
Consensus has normalized EPS growing faster than revenue in each of the next three years
Currency: IDR · Scale: money in millions, billions, absolute · YoY uses the prior fiscal year from the feed; analyst count and range use the first displayed period.
| Metric | FY2025A | FY2026E | FY2027E | FY2028E | YoY | Analysts | Low / high |
|---|---|---|---|---|---|---|---|
| Revenue | IDR 72,064 | IDR 80,171 | IDR 86,373 | IDR 98,540 | — | 7 | IDR 70,584 / IDR 73,163 |
| EBITDA | IDR 2,826 | IDR 3,266 | IDR 3,691 | IDR 4,021 | — | 4 | IDR 2,346 / IDR 3,221 |
| EPS (normalized) | IDR 69.56 | IDR 79.58 | IDR 90.63 | IDR 103.9 | — | 6 | IDR 62.00 / IDR 73.27 |
| Gross margin | 11.3% | 11.3% | 11.4% | 11.5% | — | — | — |
| Dividend per share | IDR 21.90 | IDR 23.20 | IDR 26.87 | IDR 30.20 | — | — | — |
Beat / miss record
Current sequences by metric: Revenue: 1 consecutive miss.
Currency: IDR · Scale: money in millions, billions, absolute · Consensus is captured before each actual first became effective.
| Quarter | Metric | Consensus | Actual | Surprise | Outcome |
|---|---|---|---|---|---|
| Q1 FY2026 | Revenue | IDR 23,893 | IDR 22,413 | -6.2% | Miss |
| Q4 FY2025 | Revenue | IDR 20,798 | IDR 24,243 | +16.6% | Beat |
| Q3 FY2025 | Revenue | IDR 17,151 | IDR 17,318 | +1.0% | Beat |
| Q1 FY2025 | Revenue | IDR 17,217 | IDR 15,882 | -7.8% | Miss |
| Q4 FY2024 | Revenue | IDR 17,123 | IDR 16,672 | -2.6% | Miss |
| Q4 FY2023 | Revenue | IDR 17,076 | IDR 17,323 | +1.4% | Beat |
| Q4 FY2022 | Revenue | IDR 13,196 | IDR 14,531 | +10.1% | Beat |
Three analysts put FY2028 EBITDA anywhere from 3,306 to 5,156
The FY2027 revenue and normalized EPS ranges each carry seven estimates and are the most informative disagreement on this page. The FY2028 EBITDA range is the widest but rests on three models, which makes it thin coverage more than a settled debate.
Currency: IDR · Scale: money in millions, billions, absolute · Spread/mean is absolute high-low divided by absolute mean.
| Metric | Period | Mean | Low–high | Spread/mean | Analysts |
|---|---|---|---|---|---|
| Revenue | FY2027E | IDR 86,373 | IDR 77,003–IDR 93,315 | 18.9% | 7 |
| EPS (normalized) | FY2027E | IDR 90.63 | IDR 84.00–IDR 101.1 | 18.8% | 7 |
| EBITDA | FY2027E | IDR 3,691 | IDR 3,045–IDR 4,352 | 35.4% | 4 |
| EBITDA | FY2028E | IDR 4,021 | IDR 3,306–IDR 5,156 | 46.0% | 3 |
Six buys, one outperform, one hold — and price targets from 400 to 680
The mean target of 504.3 sits above the median of 450, so the distribution is pulled by its high end rather than centred on it. Seven analysts contribute targets and no analyst carries a sell or underperform rating. This source has no market price, so none of this reads as upside.
Currency: IDR · Scale: money in millions, billions, absolute · Analyst counts shown explicitly.
| Street view | Reading | Analysts |
|---|---|---|
| Recommendation mix | Buy 6, Outperform 1, Hold 1, Underperform 0, Sell 0 | 8 |
| Consensus score | 1.38 | 8 |
| Target price | mean IDR 504.3; median IDR 450.0; high IDR 680.0; low IDR 400.0 | 7 |
Coverage caution: FY2028 rests on three analysts, and several lines carry no count at all
FY2028 revenue, GAAP net income and EBITDA each rest on three estimates and normalized EPS on four, against six or seven on the FY2026 and FY2027 revenue and EPS lines. Free cash flow, capex, cash from operations, net debt and ROE are supplied as a mean only, with no analyst count and no range, so their moves cannot be sized for breadth or dispersion.